Premium
BioVie Inc (BIVI)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It als... BioVie Inc., a clinical-stage biopharmaceutical company, develops drug therapies to treat neurological and neurodegenerative disorders, and advanced liver disease in the United States. The company develops BIV201, that is in phase 2 for the treatment of ascites due to chronic liver cirrhosis. It also develops NE3107 that is in Phase III clinical trial for the treatment of patients with mild to moderate Alzheimer’s disease; and in Phase 2 clinical trial to treat Parkinson’s disease, as well as for the long COVID program. The company was formerly known as NanoAntibiotics, Inc. and changed its name to BioVie Inc. in July 2016. BioVie Inc. was incorporated in 2013 and is headquartered in Carson City, Nevada. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.23 | 11.8556701031 | 1.94 | 2.29 | 1.74 | 189437 | 2.00582576 | CS |
| 4 | 0.55 | 33.950617284 | 1.62 | 2.29 | 1.55 | 180064 | 1.8733806 | CS |
| 12 | 0.67 | 44.6666666667 | 1.5 | 2.29 | 1.2588 | 126616 | 1.68462517 | CS |
| 26 | 1 | 85.4700854701 | 1.17 | 2.29 | 1.06 | 108290 | 1.50182976 | CS |
| 52 | 1.22 | 128.421052632 | 0.95 | 9.25 | 0.94 | 151976 | 1.87688251 | CS |
| 156 | -2.15 | -49.7685185185 | 4.32 | 9.25 | 0.2506 | 1013064 | 2.18428654 | CS |
| 260 | -14.42 | -86.9198312236 | 16.59 | 17 | 0.2506 | 726666 | 2.90016897 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
